HCIT, very sorry to hear about your kidney cancer. I do

New Post Public Reply Private Reply Replies (0) Message Board
Cassandra X HCIT #113483
861
HCIT, very sorry to hear about your kidney cancer. I do hope you get access to Leronlimab but in the mean time -

IF I WERE IN YOUR SHOES -

I would have my doctor or another doctor put me on Maraviroc immediately. The liver toxicity issue is exaggerated and would be of no concern for three reasons - the dire situation I was in, I could monitor for liver damage with blood tests and toxicity to the liver from cancer treatments would be much worse.

I would double up on the Maraviroc dosage, at least, as I am doing the blood tests, and I would still press hard for Leronlimab. If I couldn't get the LL, I'd make the hard choice and take more Maraviroc, as much as my liver would allow.

Too bad Maraviroc isn't the elegant molecule that LL is but it is a CCR5 antagonist. If it helped, I would pretend I was in Phase 2 trial, looking for the best dosage level. Put me on the high dose.

The biggest obstacle I would find to doing this would be the doctors and hospitals trying to cover their asses. I would seek legal help if I needed to and sign any waivers I had to. Ass covering will be a problem with LL too, maybe more so because it is not an approved drug yet.

That's what I would do. Enuf said.

Best wishes to you and please keep us here on the board informed.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 4

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Court Enforces Design Rights: AEKE Blocked in Germany

Updated Category News Views 10

Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...

Continue Reading
LG's High-Purity RGB Displays Shine at IFA 2026

Updated Category News Views 2

LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 3

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 1

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Auto Maintenance: Key Tips for Long-Term Vehicle Health

Updated Category News Views 2

Beating Breakdown Blues: Preventative Maintenance Insights You ever look under the hood and wonder what's ticking away? Cars ain't just about turning keys and hitting gas—there's a beating heart under all that metal and rubber. That's what HelloNation's serving us here, with David Mantz and his kid, David Mantz Jr., lifting the lid on preventative maintenance. These...

Continue Reading
Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Updated Category News Views 1

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

Continue Reading
UGREEN's AI Hub: Privacy-First Tech for Smart Homes

Updated Category News Views 1

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...

Continue Reading

Top 5 Most Recently Viewed Articles

Troilus Gold Corp. Successfully Completes Major Offering

Updated Category News Views 155

Troilus Gold Corp. Completes Significant Public Offering MONTRÉAL — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG, OTCQX: CHXMF; FSE: CM5R) is excited to share that it has successfully closed a major bought deal public offering, which included the full exercise of the over-allotment option. This offering has resulted in the issuance of 133,722,000...

Continue Reading
Euro Zone Households' Savings: A Path to Economic Recovery

Updated Category News Views 162

Understanding Households’ Savings Trends in the Euro Zone In recent discussions regarding economic trends, it is evident that households in the Euro zone are tightening their financial belts and focusing on saving. According to the European Central Bank (ECB), many families are prioritizing the rebuilding of their wealth that was eroded due to soaring inflation. This...

Continue Reading
Harbor Capital Enhances Industrial Reach Through Strategic Buy

Updated Category News Views 132

Harbor Capital's Expansion Strategy in Industrial Real Estate In a notable move to enhance its industrial portfolio, Harbor Capital has announced the acquisition of a significant industrial facility, located at 190 Industrial Blvd. This impressive 51,710-square-foot property is strategically positioned to support the evolving needs of logistics and manufacturing sectors....

Continue Reading
IQSTEL Reports Third Quarter Surge with $102.8 Million Revenue

Updated Category News Views 138

IQSTEL Inc. Achieves Outstanding Revenue Growth in Q3 IQSTEL Inc. (NASDAQ: IQST) has recently revealed its impressive financial performance for the third quarter, showcasing a remarkable net revenue of $102.8 million. This marks a significant 42% increase from the $72.1 million reported in the previous quarter. The latest growth figures highlight the company’s robust...

Continue Reading
Oppenheimer Affirms Support for Bicycle Therapeutics' Growth

Updated Category News Views 62

Oppenheimer's Positive Perspective on Bicycle Therapeutics Recently, Oppenheimer has underscored its supportive stance on Bicycle Therapeutics (NASDAQ: BCYC) by maintaining an Outperform rating along with a price target of $48. This affirmation is fueled by recent presentations that preview a significant radiopharmaceutical gathering and insights from the company's...

Continue Reading